MaxCyte
MXCT
102 hedge funds and large institutions have $321M invested in MaxCyte in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 15 closing their positions.
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
23% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 30
4% more funds holding
Funds holding: 98 → 102 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.49% less ownership
Funds ownership: 67.47% → 66.98% (-0.49%)
36% less capital invested
Capital invested by funds: $502M → $321M (-$181M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$6.44M |
| 2 |
Millennium Management
New York
|
+$4.66M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.24M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$3.35M |
| 5 |
VP
Vitruvian Partners
London,
United Kingdom
|
+$3.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
D1 Capital Partners
New York
|
-$24.5M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$23.3M |
| 3 |
BAMCO Inc
New York
|
-$10.9M |
| 4 |
RA
Royce & Associates
New York
|
-$5.57M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$5.43M |
MXCT Hedge Fund Activity: Q2 2022 in Review
102 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2022, worth a combined $321M — down 36% from $502M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new MXCT positions and 15 closed out — a net gain of 6 holders — while 37 added to existing stakes and 30 trimmed.
The largest buyer was Citigroup, adding an estimated $6.44M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $24.5M sold.
- 102 institutional investors held MaxCyte (MXCT) as of Q2 2022, up from 98 in Q1 2022.
- Funds reported $321M of MaxCyte stock for Q2 2022, down 36% quarter-over-quarter.
- 21 funds opened new MaxCyte positions in Q2 2022 and 15 closed out, a net change of +6 holders.
- The largest MaxCyte buyer in Q2 2022 was Citigroup, an estimated $6.44M added.
- The largest MaxCyte seller in Q2 2022 was D1 Capital Partners, an estimated $24.5M sold.
Based on aggregated 13F filings for Q2 2022.